Attached files

file filename
10-Q - CBRX FORM 10-Q - COLUMBIA LABORATORIES INCa2012q110q.htm
EX-32.2 - EXHIBIT 32.2 - COLUMBIA LABORATORIES INCa2012q1ex322.htm
EX-32.1 - EXHIBIT 32.1 - COLUMBIA LABORATORIES INCa2012q1ex321.htm
EX-31.1 - EXHIBIT 31.1 - COLUMBIA LABORATORIES INCa2012q1ex-311.htm
EXCEL - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR6.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR8.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR7.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR1.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR3.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR9.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR5.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR2.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR14.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR18.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR10.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR12.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR15.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR11.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR19.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR17.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR20.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR16.htm
XML - IDEA: XBRL DOCUMENT - COLUMBIA LABORATORIES INCR13.htm
EX-31.2 - EXHIBIT 31.2 - COLUMBIA LABORATORIES INCa2012q1ex-312.htm
v2.4.0.6
Condensed Consolidated Statements of Operation (USD $)
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
REVENUES    
Net product revenues (including amounts from related party: three months 2012 - $240,401; 2011 - $426,780 ) $ 3,118,632 $ 3,464,944
Royalties (including amounts from related party: three months 2012 - $600,000; 2011 - $540,000) 680,377 600,813
Other revenues (including amounts from related party: three months 2012 - $0 ; 2011 - $8,393,926) 34,532 8,428,582
Total net revenues 3,833,541 12,494,339
COST OF PRODUCT REVENUES    
Cost of product revenues (including amounts from related party: three months 2012 - $218,546 ; 2011 - $388,133) 2,002,986 2,034,838
Gross profit 1,830,555 10,459,501
OPERATING EXPENSES:    
Selling and distribution 0 57,842
General and administrative 2,551,325 2,356,478
Research and development (net of reimbursement from related party: three months 2012 - $428,031; 2011 - $0 ) 553,678 1,345,601
Total operating expenses 3,105,003 3,759,921
(Loss) income from operations (1,274,448) 6,699,580
OTHER INCOME (EXPENSE):    
Interest income 59,121 1,525
Interest expense 0 (3,888)
Change in fair value of redeemable warrants 0 (2,721,205)
Change in fair value of stock warrants 6,259,367 (5,058,111)
Other, net (86,971) (101,860)
Total other income (expense) 6,231,517 (7,883,539)
Income (loss) before taxes 4,957,069 (1,183,959)
Provision for income taxes (2,676) (2,928)
NET INCOME (LOSS) $ 4,954,393 $ (1,186,887)
NET INCOME (LOSS) PER COMMON SHARE:    
Basic $ 0.06 $ (0.01)
Diluted $ (0.02) $ (0.01)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING:    
Basic 87,295,985 83,703,219
Diluted 87,295,985 83,703,219